| For: | Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918 [PMID: 40094147 DOI: 10.4292/wjgpt.v16.i1.97918] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i1/97918.htm |
| Number | Citing Articles |
| 1 |
Mohammed Amer Kamel, Yonatan Abbawa Zewdie, Sai Venkata Siddhartha Masetti, Mira Odeessa Pereira, Maham Afzal, Akash Rawat, Sahibzada Zumeran Jah Jah, Prachi P. Salunke, Suhas Kataveni, Zainab Shaheen, Abdulrahman Bukamal, Shahad Abu Ahmad, Mirza Muhammad Hadeed Khawar, Asraf Hussain. Magnetic sphincter augmentation versus fundoplication for GERD: a systematic review and meta-analysis of postoperative outcomes. Annals of Medicine & Surgery 2026; 88(2) doi: 10.1097/MS9.0000000000004522
|
| 2 |
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Davide Bona, Leonardo Vincenti, Adolfo Renzi, Luigi Bonavina. Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04747-z
|
| 3 |
Eman Mohammed Fallata, Inyoung Lee, Osama Abdulwahed Bakkari, Abdulaziz A. AlMulhem, Sultan Sulaiman A. Alayed, Sungsoo Park. Optimizing outcomes in antireflux surgery: anticipating GERD symptom resolution after laparoscopic Nissen fundoplication. Foregut Surgery 2026; 6(2) doi: 10.51666/fs.2026.6.e6
|
| 4 |
I. G. Bakulin, N. V. Bakulina, Yu. G. Topalova, S. V. Tikhonov, N. V. Pavlova. “GeFest” questionnaire: New diagnostic options for GERD and functional dyspepsia. Meditsinskiy sovet = Medical Council 2025; (15) doi: 10.21518/ms2025-430
|
| 5 |
А.А. Бражникова, И.П. Магомедова, А.У. Мирзошарипова, Т.К. Борлакова, А.В. Хисамова.
Сравнительный анализ эффективности ингибиторов протонной помпы и калий-конкурентных блокаторов кислоты у пациентов с гастроэзофагеальной рефлюксной болезнью
. International Journal of Medicine and Psychology 2026; 9(4) doi: 10.58224/2658-3313-2026-9-4-87-94
|
| 6 |
Tingting Xu, Fuxing Wen, Jiayuan Zhao, Wei Zhang. Endoscopic Anti-Reflux Mucosal Interventions for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Comparative Outcomes. Digestive Diseases 2025; 43(6) doi: 10.1159/000548198
|
| 7 |
Takayoshi Tsubaki, Masami Hashidume, Keimei Kato. Result of Potassium-Competitive Acid Blockers in the Treatment of Severe Gastroesophageal Reflux Disease-Associated Esophageal Ulcer. Cureus 2026; doi: 10.7759/cureus.105634
|
| 8 |
O.M. Shevtsova. Gastroesophageal reflux disease and excess body weight: current understanding of the mechanisms of development. The role of metabolic phenotypes of obesity. Part 1. GASTROENTEROLOGY 2026; 60(2) doi: 10.22141/2308-2097.60.2.2026.730
|
| 9 |
Katriane C. da Silva, Isaac Alef B. Gomes, Francisca Beatriz de M. Sousa, Arícia G. Miranda, Marcelo B. Gois, Jand Venes R. Medeiros, William Harnett, Lucas A.D. Nicolau. Gastro-oesophageal reflux disease as a disorder of immune dysregulation driven by microbial deprivation: Extending the hygiene hypothesis to the oesophagus. Medical Hypotheses 2026; 214 doi: 10.1016/j.mehy.2026.112090
|
| 10 |
Yi Yang, Xueying Yin, Xiaoyan Wang, Jing Zhang, Jun Yu, Fengming Yue, Lixia Wang, Dong Yang, Zhifeng Zhang, Xiaoyu Sun, Xiukun Hou, Zhijun Duan. Reflux esophagitis patients exhibit reduced gastric tolerance, impaired slow-wave activity and esophageal dysmotility. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1897880
|
| 11 |
Alsu R. Khurmatullina, Dmitrii N. Andreev, Igor V. Maev, Svetlana V. Lyamina, Yury A. Kucheryavyy, Petr A. Beliy, Filipp S. Sokolov. Global prevalence and risk of gastroesophageal reflux disease symptoms in pregnancy: a systematic review and meta-analysis. BMC Pregnancy and Childbirth 2025; 26(1) doi: 10.1186/s12884-025-08569-x
|
| 12 |
Yongqi Dong, Shengsheng Xu, Gang Zhao, Xuecai Zeng. Global burden of gastroesophageal reflux disease, 1990–2021, with projections to 2040: an update from the global burden of disease study 2021. Diseases of the Esophagus 2025; 38(6) doi: 10.1093/dote/doaf113
|
| 13 |
Mohammad A. Jareebi, Yara A. Mutaen, Hanin J. Mobarki, Alaa A. Faqihi, Shahad A. Ageeli, Rana M. Qaseeri, Walaa A. Ajimi, Norah A. Alhazmi, Saja A. Almraysi, Majed A. Ryani, Farjah H. Algahtani, Ahmed A. Bahri, Abdulwahab A. Aqeeli, Nabeel Mohammed Alkhairat, Adhari A. Alselmi. Behavioral–Gastrointestinal Interaction Between Night Eating Syndrome and GERD Among Saudi Adults: Implications for Clinical Screening and Lifestyle-Based Care. Healthcare 2026; 14(5) doi: 10.3390/healthcare14050636
|
| 14 |
W Cordier. Calming the acid: Pharmacotherapeutic approaches to gastro-oesophageal reflux disorder. SA Pharmaceutical Journal 2025; 92(6) doi: 10.36303/SAPJ.3551
|
| 15 |
Nilanka Wickramasinghe, Ahthavann Thuraisingham, Achini Jayalath, Dharmabandu Nandadeva Samarasekera, Etsuro Yazaki, Ranil Jayawardena, Niranga Manjuri Devanarayana. Dietary and nutritional correlates of gastroesophageal reflux disease symptoms: A comprehensive island-wide study in Sri Lanka. World Journal of Gastrointestinal Surgery 2026; 18(3): 113687 doi: 10.4240/wjgs.v18.i3.113687
|
| 16 |
Xuemei Liu, Decheng Deng, Jian Meng, Haitang Hu, Quankun Zhuang, Xue Zhou, Long Fu, Binke Fan, Xueting Xu, Qin Huang, Xiaoyan Chen, Fang Hou. Pharmacokinetics, mass balance, and metabolism of the novel potassium-competitive acid blocker JP-1366 in healthy Chinese adults following a single oral dose of [14C]JP-1366. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1701581
|
| 17 |
Zehra Tunçbilek, Gürcan Doğukan Arslan, Songül Kılıç, Muhammed Türk, Feyza Önder. Gastroesophageal and laryngopharyngeal reflux symptoms in patients with primary acquired nasolacrimal duct obstruction and controls: a comparative study. International Ophthalmology 2026; 46(1) doi: 10.1007/s10792-026-04190-9
|
| 18 |
Hideki Mizuno, Shingo Inagaki, Kazutoshi Yamada, Shinji Kamiyamamoto. Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease. Biomedical Reports 2025; 23(4) doi: 10.3892/br.2025.2038
|
| 19 |
P. A. Chizhkov, V. N. Kalaev. Genetic factors predisposing to the development of gastroesophageal reflux disease (literature review). Yakut Medical Journal 2026; (2) doi: 10.25789/YMJ.2026.94.22
|
| 20 |
Xiao Longwu, Xia Teng. A socioeconomic perspective on the global burden of gastroesophageal reflux disease (1990–2021): findings from the GBD 2021. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04389-7
|
| 21 |
Kai-Juan Cao, Long Fu, Yu-Chen Sun, Jian Meng, Qin Huang, De-Cheng Deng, Hai-Tang Hu, Zhi-Hui Han, Gang Guo, Xue Zhou, Xiao-Yan Chen. CYP3A-Mediated Metabolism of Zastaprazan in Humans and Associated Drug–Drug Interactions. Pharmaceutics 2026; 18(6) doi: 10.3390/pharmaceutics18060718
|